Contrast Magnetic Resonance Imaging in the Assessment of Myocardial Viability in Patients With Stable Coronary Artery Disease and Left Ventricular Dysfunction
- 15 December 1998
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 98 (24), 2687-2694
- https://doi.org/10.1161/01.cir.98.24.2687
Abstract
Background —The utility of contrast MRI for assessing myocardial viability in stable coronary artery disease (CAD) with left ventricular dysfunction is uncertain. We therefore performed cine and contrast MRI in 24 stable patients with CAD and regional contractile abnormalities and compared MRI findings with rest-redistribution 201 Tl imaging and dobutamine echocardiography. Methods and Results —Delayed MRI contrast enhancement patterns were examined from 3 to 15 minutes after injection of 0.1 mmol/kg IV gadolinium diethylenetriamine pentaacetic acid (Gd-DTPA). Comparable MRI and 201 Tl basal and midventricular short-axis images were subdivided into 6 segments. Segments judged nonviable by quantitative and qualitative assessment of 201 Tl scans showed persistent, systematically greater MRI contrast signal intensity than segments judged viable ( P ≤0.002). Delayed contrast hyperenhancement also occurred in segments judged nonviable by dobutamine echocardiography ( P ≤0.03). The presence or absence of hyperenhancement correlated most closely with nonviability and viability, respectively, in segments that were akinetic or dyskinetic under resting conditions (83% concordance with 201 Tl in both cases). In segments with resting hypokinesis, 58% of segments showing hyperenhancement were judged viable by 201 Tl and may have represented an admixture of scar tissue and viable myocardium. Conclusions —Delayed (by 3 to 15 minutes) hyperenhancement of Gd-DTPA contrast–enhanced MRI images occurs frequently in dysfunctional areas of the left ventricle in patients with stable CAD. Hyperenhancement is associated with nonviability by rest-redistribution 201 Tl scintigraphy and dobutamine echocardiography, particularly in regions exhibiting resting akinesis/dyskinesis. The absence of hyperenhancement correlates with radionuclide and echocardiographic determinations of viability, regardless of resting contractile function.Keywords
This publication has 14 references indexed in Scilit:
- The determination of myocardial viability using Gd‐DTPA in a canine model of acute myocardial ischemia and reperfusionMagnetic Resonance in Medicine, 1996
- Stress Echocardiography. Part II. Dobutamine Stress Echocardiography: Techniques, Implementation, Clinical Applications, and CorrelationsMayo Clinic Proceedings, 1995
- Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction: Role of magnetic resonance imagingAmerican Heart Journal, 1994
- Usefulness of ultrafast magnetic resonance imaging in healed myocardial infarctionThe American Journal of Cardiology, 1992
- Chronic myocardial infarction: Assessment of morphology, function, and perfusion by gradient echo magnetic resonance imaging and 99mTc-methoxyisobutyl-isonitrile SPECTAmerican Heart Journal, 1992
- Recommendations for Quantitation of the Left Ventricle by Two-Dimensional EchocardiographyJournal of the American Society of Echocardiography, 1989
- Gadolinium-DTPA-enhanced nuclear magnetic resonance imaging of reperfused myocardium: Identification of the myocardial bed at riskJournal of the American College of Cardiology, 1988
- Magnetic resonance imaging (MRI) in different stages of myocardial infarction using the contrast agent gadolinium‐DTPAClinical Cardiology, 1986
- Occlusive and reperfused myocardial infarcts: effect of Gd-DTPA on ECG-gated MR imaging.Radiology, 1986
- Contrast-enhanced NMR imaging: animal studies using gadolinium-DTPA complexAmerican Journal of Roentgenology, 1984